November 25, 2013

Vanda Pharmaceuticals Inc. et al v. Roxane Laboratories Inc.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. August 25, 2016

    Roxane Infringed Vanda's Antipsychotic Patent, Judge Rules

    Two of Vanda Pharmaceutical’s patents for its schizophrenia drug Fanapt are valid, and Roxane Laboratories Inc. violated one of them when attempting to make a generic, a Delaware federal judge ruled Thursday.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS